Inventor
SHULMAN AVIDOR
IL37 patents
⚠️ This page may combine multiple inventors who share the name “SHULMAN AVIDOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENZYMOTEC LTD
8 patentsUS7935365B2May 3, 2011
Glycerophospholipids for the improvement of cognitive functions
ENZYMOTEC LTD26 citations90
US9585966B2Mar 7, 2017
Glycerophospholipids for the improvement of cognitive functions
ENZYMOTEC LTD3 citations82
US8052992B2Nov 8, 2011
Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
ENZYMOTEC LTD8 citations82
US7968112B2Jun 28, 2011
Lipids containing omega-3 and omega-6 fatty acids
ENZYMOTEC LTD9 citations82
US7034168B2Apr 25, 2006
Process for the production of phospholipids
ENZYMOTEC LTD8 citations70
US10004247B2Jun 26, 2018
Process for the preparation of human milk fat substitutes
ENZYMOTEC LTD2 citations67
US9962455B2May 8, 2018
Glycerophospholipids for the improvement of cognitive functions
ENZYMOTEC LTD0 citations50
US9782487B2Oct 10, 2017
Glycerophospholipids for the improvement of cognitive functions
ENZYMOTEC LTD0 citations50
PROTALIX LTD
8 patentsUS9708595B2Jul 18, 2017
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD4 citations82
US10870842B2Dec 22, 2020
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD2 citations71
US10280414B2May 7, 2019
Stabilized α-galactosidase and uses thereof
PROTALIX LTD3 citations71
US9603907B2Mar 28, 2017
Dry powder formulations of dNase I
PROTALIX LTD2 citations69
US11225648B2Jan 18, 2022
Modified DNase and uses thereof
PROTALIX LTD4 citations65
US12385026B2Aug 12, 2025
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD0 citations60
US11814657B2Nov 14, 2023
Modified DNase and uses thereof
PROTALIX LTD0 citations55
US9603906B2Mar 28, 2017
Inhalable liquid formulations of DNase I
PROTALIX LTD0 citations48
SHULMAN AVIDOR
7 patentsUS9194011B2Nov 24, 2015
Stabilized alpha-galactosidase and uses thereof
SHULMAN AVIDOR8 citations81
US8618050B2Dec 31, 2013
Lipid preparation for enhancing mineral absorption
SHULMAN AVIDOR5 citations71
US9332771B2May 10, 2016
Human milk fat substitutes
SHULMAN AVIDOR2 citations56
US9732333B2Aug 15, 2017
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
SHULMAN AVIDOR0 citations50
US8772270B2Jul 8, 2014
Treatment methods requiring phyto-ingredients
SHULMAN AVIDOR0 citations50
US8742079B2Jun 3, 2014
Saccharide-containing protein conjugates and uses thereof
SHULMAN AVIDOR0 citations50
US9814252B2Nov 14, 2017
Polar lipid mixtures, their preparation and uses
SHULMAN AVIDOR0 citations48
BIOND BIOLOGICS LTD
7 patentsUS11236162B2Feb 1, 2022
Antibodies against ILT2
BIOND BIOLOGICS LTD2 citations67
US12503510B2Dec 23, 2025
Small shedding blocking agents
BIOND BIOLOGICS LTD0 citations57
US12139534B2Nov 12, 2024
Methods and compositions for decreasing soluble immune receptor CD28
BIOND BIOLOGICS LTD1 citations57
US12589163B2Mar 31, 2026
Shedding blocking agents with increased stability
BIOND BIOLOGICS LTD0 citations56
US12391755B2Aug 19, 2025
Methods of use for anti-ILT2 antibodies
BIOND BIOLOGICS LTD0 citations56
US12071479B2Aug 27, 2024
Antibodies against ILT2 and use thereof
BIOND BIOLOGICS LTD1 citations56
US12544451B2Feb 10, 2026
Intracellular delivery compositions
BIOND BIOLOGICS LTD0 citations52